Skip to content

Clinical Study to evaluate efficacy of One Type of Cosmetic on Human Skin

Clinical Study to evaluate efficacy of One Type of Cosmetic on Human Skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011193
Enrollment
23
Registered
2025-11-21
Start date
2025-10-21
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Apply this product once daily after cleansing, gently spreading it on before bedtime.

Sponsors

Dermacle, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female aged between 40 and 70 years 2. Individuals experiencing insomnia due to aging or menopausal symptoms 3. Individuals meeting or exceeding the criteria after PSQI-K [Pittsburgh Sleep Quality Index-Korean] questionnaire assessment 4. Individuals with wrinkles around the eyes 5. Individuals with dark circles caused by vascular or pigmentary factors 6. Individuals who have fully understood the objective and have voluntarily filled out and signed a consent form after receiving sufficient explanation about the information that should be provided to the subjects by the principal investigator or their delegate 7. Healthy individuals without acute or chronic physical diseases, including skin diseases 8. Individuals who can be monitored during the study period

Exclusion criteria

Exclusion criteria: 1. Female who are pregnant, breast feeding or planning pregnancy 2. Individuals with abnormal skin findings at the test site 3. Individuals who have infectious skin diseases 4. Individuals with significant nutritional disorders 5. Individuals with drug or alcohol addiction 6. Individuals with sagging under the eyes that may be mistaken for dark circles 7. Individuals who have allergies or hypersensitive skin 8. Individuals who are sensitive to cosmetics, medications, or normal light exposure 9. Individuals who have received systemic steroids or phototherapy within 1 month of participating in the study 10. Individuals who have received skin care or procedures (scaling, Botox, fillers, laser treatments, tattoos) within 3 months of participating in the study 11. Individuals with mental illness or intellectual disabilities. 12. Individuals who have used topical steroid-containing skin preparations for more than 1 month for the treatment of skin diseases 13. Individuals who have not passed 3 months after participating in the same study 14. Other individuals who are considered unsuitable for the study by the principal investigator

Design outcomes

Primary

MeasureTime frame
Crow's feet;Skin elasticity;Skin Lifting (Angle);Skin density;Skin water loss;Dark circles(grade, brightness, melanin);Skin Volume;Skin elasticity recovery;Skin texture (roughness);Skin radiance;Skin tone;Sleep time;Sleep Questionnaire (PSQI-K);PHQ-9 Questionnaire;Identification of neuro-inflammation factors through tape stripping methodology;Detection of cortisol, melatonin, oxytocin and substanceP secreted in saliva

Secondary

MeasureTime frame
adverse reactions

Countries

Korea, Republic of

Contacts

Public ContactJeong YunJi

Dermacle, Inc.

dbswl4189@naver.com+82-31-895-4837

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Sep 19, 2026